尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the complete record of transactions filed by Pottage John C Jr. Director active across 1 company, notably Spero Therapeutics, Inc.. Aggregated, 4 filings have been recorded. Activity tracked since 15 September 2022. The latest transaction was filed on 12 June 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Pottage John C Jr is a declarant linked to Spero Therapeutics, Inc., where he is a director. He has 4 filings in total, and the 4 sampled filings run from 2022-09-19 to 2025-06-16, with transaction nature shown as Attribution and buy and sell amounts of EUR 0.